Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Bond market alert: Burnham and Streeting turn up leader rumours 

      Burnham smiling broadly at a community event, surrounded by enthusiastic supporters, conveying a sense of positivity and u...

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Why Sunderland’s away kit legal row is a warning to all sports

      Breaking news event with diverse crowd gathered at a city park, showcasing community engagement and public discourse.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      What’s on in London in May

      City skyline view with modern skyscrapers under a clear blue sky in May, reflecting urban growth and economic vibrancy

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper
  • ISA Guide
  • Sign In
  • Sign Out
  • My Account

pharmaceuticals

  • Invidior unveils $100m share repurchase scheme with new drugs powering rebounding revenues

    April 28, 2022

    Invidior has announced a $100 plan to return capital to shareholders, with the pharmaceutical firm on track to achieve its full-year guidance.

  • Martin Shkreli’s lawyers ask to drop him as client as ‘pharma bro’ owes $2m in legal fees

    April 13, 2022

    Martin Shkreli’s lawyers are seeking to drop him as a client, over claims the price-hiking pharma exec owes them $2.04m (£1.57m). Philadelphia headquartered law firm Duane Morris LLP asked for a judge’s permission to pull out of representing Shkreli after claiming the imprisoned former hedge fund manager “has no assets” to pay its fees. The [...]

  • Oxford Nanopore Technology has spike in revenue but losses up more than £100m

    March 22, 2022

    A UK-based technology research firm has had spike in revenue by £30m, but an almost £100m loss from 2020. Oxford Nanopore Technologies, which develops state-of-the-art technology to analyse individual molecules, increased its intake to £134m in 2021, up from £114m. The company’s gross profit was up from 41 per cent to almost 55 per cent, [...]

  • J&J and three other drug distributors settle opioid crisis lawsuits for $26bn

    February 25, 2022

    US pharma giant Johnson & Johnson, and three of America’s largest medical distributors, have agreed to pay $26bn (£19bn) to settle more than 3,000 lawsuits over the role they played in fuelling America’s opioid crisis. New Jersey drugmaker J&J, and medicine distributors Cardinal Health, AmerisourceBergen, and Distributors McKesson, finalized a deal through which they will [...]

  • AIDS scientists cure human for the first time: Former HIV patient is off medication, asymptomatic and healthy

    February 16, 2022

    Researchers in the U.S. have said they have cured HIV in a human being for the very first time. The scientists said the mixed-race New York woman, who was previously HIV positive, was now “off medication, asymptomatic and healthy”, according to various media reports. The scientists reportedly used a cutting-edge stem cell transplant method that [...]

  • First patient in UK gets ‘vaccine’ for cancer that should help immune system ward off cancer permanently

    February 14, 2022

    A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning, in a clinical research trial which may help bring further ground-breaking treatments for the disease. The clinical research team at The Clatterbridge Cancer Centre has given patient Graham [...]

  • Informa offloads Pharma Intelligence to Warburg Pincus for £1.9bn as firm shifts focus

    February 10, 2022

    Informa has agreed to sell Pharma Intelligence to US private equity group Warburg Pincus for £1.9bn, as the UK firm looks to boost shareholder value.

  • UK’s largest ever health research project is looking for 5 million Brits

    January 23, 2022

    A major health study which aims to predict who will get ill in their later years even before they show symptoms needs a record 5m volunteers. Hoped to be the UK’s largest ever health research programme, Our Future Health will track people throughout their lives in a bid to come up with new ways to [...]

  • France discovers new Covid variant IHU with 46 mutations amid 271,000 coronavirus infections, biggest one-day jump on record

    January 5, 2022

    French media are reporting that a new Covid variant with 46 mutations has been discovered in the country. The new strain, named IHU, has been discovered in the southwest of France and, according to multiple news outlets, intensive care and hospital admissions have been increasing in that region in recent days. So far, there are [...]

  • Boost white blood cells in immune system as they are able to fight off Omicron variant, Covid scientists find

    January 4, 2022

    The immune system’s white blood cells are able to mount an immune response against the Omicron variant of Covid-19, according to a new study. Due to Omicron having a higher number of mutations than other Covid variants, it can sometimes slip past the antibodies created by vaccination or infection. However, if the virus still does [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Page 20
  • Next

Trending Articles

  • Jet fuel shortage looms as government scrambles to secure supplies

  • Mark Kleinman: Is it lights out for Ovo Energy?

  • Pension industry 1-0 Torsten Bell

  • Labour will regret the Renters’ Rights Act

  • Diageo launches the new Scotch whisky Rare Series aimed at private clients

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited